Fate Therapeutics | 4:持股变动声明-董事 Lee Michael Stewart
Fate Therapeutics | 4:持股变动声明-董事 Redmile Group, LLC
Fate Therapeutics | 4:持股变动声明-董事 RASTETTER WILLIAM H
Fate Therapeutics | 4:持股变动声明-董事 COUGHLIN TIMOTHY
Fate Therapeutics | 4:持股变动声明-董事 Jooss Karin
Fate Therapeutics | 4:持股变动声明-董事 Agarwal Shefali
Fate Therapeutics | 4:持股变动声明-董事 Xu Yuan
Fate Therapeutics | 4:持股变动声明-董事 EPSTEIN ROBERT S
Fate Therapeutics | 4:持股变动声明-董事 MENDLEIN JOHN
Fate Therapeutics | 4:持股变动声明-董事 Redmile Group, LLC
Fate Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Redmile Group, LLC(14.9%),Jeremy C. Green(14.9%)等
Fate Therapeutics | 4:持股变动声明-高管 Dulac Edward J III
Fate Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-The Vanguard Group(9.43%)
Fate Therapeutics | SC 13G:超过5%持股股东披露文件-Boxer Capital, LLC(6.3%),Boxer Asser Management Inc.(6.3%)等
Fate Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Capital World Investors(0.0%)
Fate Therapeutics | 4:持股变动声明-高管 Wolchko J Scott
Fate Therapeutics | 4:持股变动声明-高管 Dulac Edward J III
Fate Therapeutics | 4:持股变动声明-高管 TAHL CINDY
Fate Therapeutics | 4:持股变动声明-高管 Valamehr Bahram
Fate Therapeutics | 4:持股变动声明-高管 Dulac Edward J III
暂无数据